Elevated NT-proBNP levels were part of the inclusion criteria (≥300 ng/L for non-atrial fibrillation or flutter (AFF); ≥600 ng/L for AFF) and the primary composite outcome was CV death and worsening HF. The gene discussed is NPPB; the disease is hydrops fetalis.